Corona Remedies Ltd (CORONA) — Announcement | 10 September 2026
Corona Remedies clarified that recent share volume increases are purely market-driven with no undisclosed price-sensitive information or pending corporate actions, reaffirming compliance with SEBI disclosure norms and ongoing transparency obligations.
About Corona Remedies Ltd (CORONA)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when CORONA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track CORONA — Free💡 Ask AI about this filing
📊 More CORONA filings
- Announcement — 28 September 2026Corona Remedies Ltd announced that its trading window will close on October 1, 2026, remaining shut ...
- 🔴 Insider Trading — 19 September 2026Sepia Investments Limited, Sage Investment Trust, and Anchor Partners sold 2,485,476; 51,641; and 92...
- 🔴 Insider Trading — 19 September 2026Sepia Investments Limited, Sage Investment Trust and Anchor Partners sold a combined 2,630,880 share...
- 🔴 Announcement — 18 September 2026Corona Remedies Ltd announced an analyst and investor meeting scheduled for September 23, 2026 at 2:...
- Announcement — 20 August 2026CORONA Remedies announced its officials will attend an in-person investor conference hosted by Phill...
🔥 Also filed on 10 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when CORONA files new disclosures
Track CORONA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CORONA — FreeFree account · 2 AI queries/day